VANCOUVER, British Columbia, August 1, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Pfizer (NYSE:PFE), Dendreon (NASDAQ:DNDN), Frontier (NASDAQ:FTR), BP (NYSE:BP), Allergan (NYSE:AGN), and Herbalife (NYSE:HLF).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Pfizer Inc. (NYSE:PFE): In the last trading session, shares of Pfizer Inc. (NYSE:PFE) gained 1.39% to US$24.04 and made a new 52-week high of US$24.49. The rise of Pfizer shares is after the company's releasing of second quarter 2012 financial results. For the latest quarter, revenues were US$15.1 billion, compared with US$16.5 billion in the same quarter of 2011, a decrease of 9%. Net income for the quarter was increased by 25% to US$3.3 billion from net income of US$2.6 billion a year ago. Pfizer Inc. has a market capitalization of US$180.01 billion with price range within US$16.63 - US$24.49 over the past 52 weeks. Since Pfizer insiders have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for PFE here.
Read Full Report: http://www.insiderslab.com/PR3/080112B/PFE/Pfizer.pdf
Dendreon Corporation (NASDAQ:DNDN): For the second quarter of 2012, Dendreon Corporation (NASDAQ:DNDN) post a net loss of US$96.1 million (or US$0.65 per share) compared to a net loss of US$116.0 million (or US$0.79 per share) in the same quarter of 2011. Net product revenue for the quarter was increased by 66% to US$80 million from US$48.1 million year-over-year. What's more, along with the second quarter financial report, Dendreon announced a restructuring plan with a view to accelerate the company's path to profitability and future growth. Dendreon also plans to cut 600 employees in the next 12 months. By market close, shares of Dendreon tumbled 22.98% to US$4.76 with significant volume traded, which was 5 times more than usual. The stock made a new 52-week low of US$4.70 in the last trading session. Do you think Dendreon will rebound or continue to drop? Do you think now is a good time to sell the stock? Investors could get an idea by checking this insider trade report for DNDN here.
Read Full Report: http://www.insiderslab.com/PR3/080112B/DNDN/Dendreon.pdf
Frontier Communications Corporation (NASDAQ:FTR): For the second quarter of 2012, Frontier Communications Corporation (NASDAQ:FTR) announced profit was US$18.0 million (or US$0.02 per share) dropped from profit of US$32.3 million (or US$0.03 per share) prior-year's level. Revenue for the latest quarter was US$1,258.8 million, compared with revenue of US$1,322.3 million in the second quarter of 2011. In the last trading session, Frontier shares advanced 5.66% to US$3.92 with hefty volume traded, which was 3.8 times more than average volume. Its price, as of the latest close, was up 28% compared with the 52-week low and was 94% below the 52-week high. Interested in the non-public stock trading behaviors of Frontier insiders? Investors can get the information they need by clicking the following link.
Read Full Report: http://www.insiderslab.com/PR3/080112B/FTR/Frontier.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
BP plc (ADR) (NYSE:BP):
Read Full Report: http://www.insiderslab.com/PR3/080112B/BP/BP.pdf
Allergan, Inc. (NYSE:AGN):
Read Full Report: http://www.insiderslab.com/PR3/080112B/AGN/Allergan.pdf
Herbalife Ltd. (NYSE:HLF):
Read Full Report: http://www.insiderslab.com/PR3/080112B/HLF/Herbalife.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
